Predicting new indications for approved drugs using a proteochemometric method. [electronic resource]
- Journal of medicinal chemistry Aug 2012
- 6832-48 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
1520-4804
10.1021/jm300576q doi
Animals Antineoplastic Agents--chemistry Antirheumatic Agents--chemistry Cadherins--metabolism Celecoxib Cell Line, Tumor Crystallography, X-Ray Databases, Factual Drug Discovery--methods Drug Repositioning Drugs, Investigational--chemistry Human Umbilical Vein Endothelial Cells--cytology Humans Mebendazole--chemistry Mice Models, Molecular Neovascularization, Pathologic Pharmaceutical Preparations--chemistry Protein Binding Protein Conformation Proteins--chemistry Pyrazoles--metabolism Sulfonamides--metabolism United States United States Food and Drug Administration Vascular Endothelial Growth Factor Receptor-2--metabolism